These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1310 related articles for article (PubMed ID: 17967063)

  • 21. DNA methylation-dependent epigenetic regulation of gene expression in MCF-7 breast cancer cells.
    Rivenbark AG; Jones WD; Risher JD; Coleman WB
    Epigenetics; 2006; 1(1):32-44. PubMed ID: 17998816
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inactivation of the WNT5A Alternative Promoter B Is Associated with DNA Methylation and Histone Modification in Osteosarcoma Cell Lines U2OS and SaOS-2.
    Vaidya H; Rumph C; Katula KS
    PLoS One; 2016; 11(3):e0151392. PubMed ID: 26978652
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential regulation of CpG island methylation within divergent and unidirectional promoters in colorectal cancer.
    Namba S; Sato K; Kojima S; Ueno T; Yamamoto Y; Tanaka Y; Inoue S; Nagae G; Iinuma H; Hazama S; Ishihara S; Aburatani H; Mano H; Kawazu M
    Cancer Sci; 2019 Mar; 110(3):1096-1104. PubMed ID: 30637877
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regional methylation of the 5' end CpG island of BRCA1 is associated with reduced gene expression in human somatic cells.
    Magdinier F; Billard LM; Wittmann G; Frappart L; Benchaïb M; Lenoir GM; Guérin JF; Dante R
    FASEB J; 2000 Aug; 14(11):1585-94. PubMed ID: 10928993
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chromosomal losses are associated with hypomethylation of the gene-control regions in the stomach with a low number of active genes.
    Jung YC; Hong SJ; Kim YH; Kim SJ; Kang SJ; Choi SW; Rhyu MG
    J Korean Med Sci; 2008 Dec; 23(6):1068-89. PubMed ID: 19119454
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The p16-specific reactivation and inhibition of cell migration through demethylation of CpG islands by engineered transcription factors.
    Zhang B; Xiang S; Zhong Q; Yin Y; Gu L; Deng D
    Hum Gene Ther; 2012 Oct; 23(10):1071-81. PubMed ID: 22738793
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Double strand breaks can initiate gene silencing and SIRT1-dependent onset of DNA methylation in an exogenous promoter CpG island.
    O'Hagan HM; Mohammad HP; Baylin SB
    PLoS Genet; 2008 Aug; 4(8):e1000155. PubMed ID: 18704159
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of novel tumor markers in prostate, colon and breast cancer by unbiased methylation profiling.
    Chung W; Kwabi-Addo B; Ittmann M; Jelinek J; Shen L; Yu Y; Issa JP
    PLoS One; 2008 Apr; 3(4):e2079. PubMed ID: 18446232
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Deoxyribonucleic acid methylation profiling of single human blastocysts by methylated CpG-island amplification coupled with CpG-island microarray.
    Huntriss J; Hemmings K; Baskaran P; Hazelwood L; Elder K; Virtanen C; Miller D; Picton HM
    Fertil Steril; 2015 Jun; 103(6):1566-71.e1-4. PubMed ID: 25914096
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Distribution, silencing potential and evolutionary impact of promoter DNA methylation in the human genome.
    Weber M; Hellmann I; Stadler MB; Ramos L; Pääbo S; Rebhan M; Schübeler D
    Nat Genet; 2007 Apr; 39(4):457-66. PubMed ID: 17334365
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MN1 overexpression is driven by loss of DNMT3B methylation activity in inv(16) pediatric AML.
    Larmonie NSD; Arentsen-Peters TCJM; Obulkasim A; Valerio D; Sonneveld E; Danen-van Oorschot AA; de Haas V; Reinhardt D; Zimmermann M; Trka J; Baruchel A; Pieters R; van den Heuvel-Eibrink MM; Zwaan CM; Fornerod M
    Oncogene; 2018 Jan; 37(1):107-115. PubMed ID: 28892045
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence that silencing of the HPRT promoter by DNA methylation is mediated by critical CpG sites.
    Chen C; Yang MC; Yang TP
    J Biol Chem; 2001 Jan; 276(1):320-8. PubMed ID: 11013250
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer.
    Cameron EE; Bachman KE; Myöhänen S; Herman JG; Baylin SB
    Nat Genet; 1999 Jan; 21(1):103-7. PubMed ID: 9916800
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A genome-wide screen for normally methylated human CpG islands that can identify novel imprinted genes.
    Strichman-Almashanu LZ; Lee RS; Onyango PO; Perlman E; Flam F; Frieman MB; Feinberg AP
    Genome Res; 2002 Apr; 12(4):543-54. PubMed ID: 11932239
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A new class of tissue-specifically methylated regions involving entire CpG islands in the mouse.
    Suzuki M; Sato S; Arai Y; Shinohara T; Tanaka S; Greally JM; Hattori N; Shiota K
    Genes Cells; 2007 Dec; 12(12):1305-14. PubMed ID: 18076568
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Methyl-CpG-binding protein MBD2 plays a key role in maintenance and spread of DNA methylation at CpG islands and shores in cancer.
    Stirzaker C; Song JZ; Ng W; Du Q; Armstrong NJ; Locke WJ; Statham AL; French H; Pidsley R; Valdes-Mora F; Zotenko E; Clark SJ
    Oncogene; 2017 Mar; 36(10):1328-1338. PubMed ID: 27593931
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Altered chromatin structure associated with methylation-induced gene silencing in cancer cells: correlation of accessibility, methylation, MeCP2 binding and acetylation.
    Nguyen CT; Gonzales FA; Jones PA
    Nucleic Acids Res; 2001 Nov; 29(22):4598-606. PubMed ID: 11713309
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Larger numbers of silenced genes in cancer cell lines with increased de novo methylation of scattered CpG sites.
    Moriguchi K; Yamashita S; Tsujino Y; Tatematsu M; Ushijima T
    Cancer Lett; 2007 May; 249(2):178-87. PubMed ID: 16971039
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DNA methyltransferase 1 knockdown induces silenced CDH1 gene reexpression by demethylation of methylated CpG in hepatocellular carcinoma cell line SMMC-7721.
    Fan H; Zhao Z; Quan Y; Xu J; Zhang J; Xie W
    Eur J Gastroenterol Hepatol; 2007 Nov; 19(11):952-61. PubMed ID: 18049164
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aberrant promoter methylation of the ABCG2 gene in renal carcinoma.
    To KK; Zhan Z; Bates SE
    Mol Cell Biol; 2006 Nov; 26(22):8572-85. PubMed ID: 16954373
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 66.